Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-03-20 | 2026-03-20 |
| Drug Identification Number | 02534150 | 02534150 |
| Brand name | JAMP SITAGLIPTIN | JAMP SITAGLIPTIN |
| Common or Proper name | Sitagliptin Tablets | Sitagliptin Tablets |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients | SITAGLIPTIN | SITAGLIPTIN |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | Bottle / Bouteille 100 | Bottle / Bouteille 100 |
| Additional packaging sizes | ||
| ATC code | A10BH | A10BH |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage (Changed) | Updated to: Disruption of the manufacture of the drug. | Was: Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2026-03-12 | 2026-03-12 |
| Estimated end date | 2026-03-13 | 2026-03-13 |
| Actual end date (Changed) | Updated to: 2026-03-20 | Was: |
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Other format available | Was: Other format available, Manufacturer delay |
| Health Canada comments |